ArticleFrontiers in veterinary science2026
Biological variation of baseline serum cortisol concentration in healthy dogs, part 2: clinical applications.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Biological variation tools can be used to quantify uncertainty inherent in laboratory measurements and assist veterinarians in clinical decision making. Methods: Biological variation tools for interpretation of baseline cortisol concentrations in dogs are calculated using data obtained during part 1 of this study. Results: Expanded measurement uncertainty and bidirectional dispersion with 95% probability for baseline cortisol are 13.7 and 64.9% respectively, and these values can be used to establish a "grey-zone" around a population-based reference interval limit to guide clinical investigations. Index of individuality is intermediate (1.14), and forty-two samples would be needed to estimate an individual dog's homeostatic setpoint for cortisol. These values support current recommendations to interpret baseline cortisol concentrations in a broader clinical context utilizing ancillary testing when appropriate. The unidirectional reference change value for baseline cortisol is 77.3% with 95% probability, which can be helpful in determining the significance of changes in serial measurements. Discussion: Biological variation tools help define uncertainty around measurement of baseline cortisol concentrations in dogs, encourage an individualized approach to spectrum-of-care, and reinforce current consensus statements that rely on clinical signs combined with dynamic testing for the diagnosis of hyper- or hypoadrenocorticism rather than baseline cortisol concentrations alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.